Study to Assess the Efficacy and Safety of ACT-541468 (Daridorexant) in Adult and Elderly Subjects With Insomnia Disorder
Clinical trial NCT03545191 · COMPLETED
Trial details
- NCT number
- NCT03545191
- Sponsor
- Idorsia Pharmaceuticals Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-04
- Primary completion
- 2020-01-25
- Enrollment
- 930
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.